Denali Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Denali Advisors's LLY Position: Q2 2026 in Review
Denali Advisors increased its Eli Lilly (LLY) stake by 39% in Q2 2026, buying an estimated $3.7M and bringing the position to 12,917 shares worth $15.5M. The position accounts for 1.56% of the portfolio, ranked #6.
Denali Advisors first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Denali Advisors held 12,917 shares of Eli Lilly worth $15.5M as of Q2 2026.
- Denali Advisors bought 3,625 Eli Lilly shares in Q2 2026, an estimated $3.7M.
- Eli Lilly made up 1.56% of Denali Advisors's portfolio in Q2 2026, its #6 holding.
- Denali Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Denali Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.